Texas Ibogaine Research Corporation
Tracked across 1 events · 6 articles · First seen Sep 14, 2026 · Last active Sep 14, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Psyence Biomedical Ltd. (Nasdaq: PBM) announced on September 14, 2026 the formation of Texas Ibogaine Research Corporation (TIRC), a Texas-based company established to coordinate the Company's U.S. ibogaine development activities, including pharmaceutical-grade supply, regulatory engagement…
Impact: TIRC is the newly formed Texas subsidiary intended to hold U.S. rights to pharmaceutical-grade ibogaine and coordinate supply, manufacturing, regulatory and clinical activities. Its value depends on completing definitive licensing arrangements with PsyLabs.
Sep 14, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Texas Ibogaine Research Corporation live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard